- Home
- IMCC vs XAIR Comparison
IMCC vs XAIR Comparison
Compare IMCC & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMCC | XAIR |
|---|---|---|
| Founded | 1980 | 2011 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4M | 10.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IMCC | XAIR |
|---|---|---|
| Price | $1.64 | $1.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 122.8K | ★ 143.2K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $37,606,703.00 | $5,802,000.00 |
| Revenue This Year | $47.12 | $128.45 |
| Revenue Next Year | $12.83 | $153.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 1.92 | ★ 147.74 |
| 52 Week Low | $0.93 | $1.00 |
| 52 Week High | $7.12 | $11.20 |
Technical Indicators
Market Signals| Indicator | IMCC | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 52.41 | 33.65 |
| Support Level | $1.54 | $1.10 |
| Resistance Level | $1.84 | $1.31 |
| Average True Range (ATR) | 0.17 | 0.12 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 66.12 | 35.29 |
Price Performance
Historical ComparisonAbout IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.